Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy AnPac Bio-Medical Science CoLtd stock | 3.48

Own AnPac Bio-Medical Science CoLtd stock in just a few minutes.


Fact checked

AnPac Bio-Medical Science Co., Ltd is a biotechnology business based in the US. AnPac Bio-Medical Science CoLtd shares (ANPC) are listed on the NASDAQ and all prices are listed in US Dollars. AnPac Bio-Medical Science CoLtd employs 111 staff and has a market cap (total outstanding shares value) of USD$39.2 million.

How to buy shares in AnPac Bio-Medical Science CoLtd

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for AnPac Bio-Medical Science CoLtd. Find the stock by name or ticker symbol: ANPC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AnPac Bio-Medical Science CoLtd reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$3.48, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AnPac Bio-Medical Science CoLtd, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of AnPac Bio-Medical Science CoLtd. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted AnPac Bio-Medical Science CoLtd's share price?

Since the stock market crash in March caused by coronavirus, AnPac Bio-Medical Science CoLtd's share price has had significant negative movement.

Its last market close was USD$3.48, which is 63.98% down on its pre-crash value of USD$9.66 and 50.00% down on the lowest point reached during the March crash when the shares fell as low as USD$5.22.

If you had bought USD$1,000 worth of AnPac Bio-Medical Science CoLtd shares at the start of February 2020, those shares would have been worth USD$692.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$327.68.

AnPac Bio-Medical Science CoLtd share price

Use our graph to track the performance of ANPC stocks over time.

AnPac Bio-Medical Science CoLtd shares at a glance

Information last updated 2020-10-19.
Latest market closeUSD$3.48
52-week rangeUSD$3.2 - USD$12.18
50-day moving average USD$4.3399
200-day moving average USD$6.2951
Wall St. target priceUSD$18
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AnPac Bio-Medical Science CoLtd stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AnPac Bio-Medical Science CoLtd price performance over time

Historical closes compared with the close of $3.48 from 2020-10-19

1 week (2020-10-22) -0.57%
1 month (2020-09-29) -11.90%
3 months (2020-07-29) -51.53%
6 months (2020-04-29) -54.81%
1 year (2019-10-25) N/A
2 years (2018-10-25) N/A
3 years (2017-10-25) N/A
5 years (2015-10-25) N/A

AnPac Bio-Medical Science CoLtd financials

Gross profit TTM USD$4.8 million
Return on assets TTM -105.3%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation USD$39.2 million

TTM: trailing 12 months

Shorting AnPac Bio-Medical Science CoLtd shares

There are currently 8,023 AnPac Bio-Medical Science CoLtd shares held short by investors – that's known as AnPac Bio-Medical Science CoLtd's "short interest". This figure is 11.6% down from 9,079 last month.

There are a few different ways that this level of interest in shorting AnPac Bio-Medical Science CoLtd shares can be evaluated.

AnPac Bio-Medical Science CoLtd's "short interest ratio" (SIR)

AnPac Bio-Medical Science CoLtd's "short interest ratio" (SIR) is the quantity of AnPac Bio-Medical Science CoLtd shares currently shorted divided by the average quantity of AnPac Bio-Medical Science CoLtd shares traded daily (recently around 133716.66666667). AnPac Bio-Medical Science CoLtd's SIR currently stands at 0.06. In other words for every 100,000 AnPac Bio-Medical Science CoLtd shares traded daily on the market, roughly 60 shares are currently held short.

To gain some more context, you can compare AnPac Bio-Medical Science CoLtd's short interest ratio against those of similar companies.

  • Amgen (AMGN.US): 2.24
  • BeiGene (BGNE.US): 9.86
  • Corcept Therapeutics Incorporated (CORT.US): 2.88

However AnPac Bio-Medical Science CoLtd's short interest can also be evaluated against the total number of AnPac Bio-Medical Science CoLtd shares, or, against the total number of tradable AnPac Bio-Medical Science CoLtd shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AnPac Bio-Medical Science CoLtd's short interest could be expressed as 0% of the outstanding shares (for every 100,000 AnPac Bio-Medical Science CoLtd shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable AnPac Bio-Medical Science CoLtd shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AnPac Bio-Medical Science CoLtd.

Find out more about how you can short AnPac Bio-Medical Science CoLtd stock.

AnPac Bio-Medical Science CoLtd share dividends

We're not expecting AnPac Bio-Medical Science CoLtd to pay a dividend over the next 12 months.

You may also wish to consider:

AnPac Bio-Medical Science CoLtd overview

Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site